News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,602 Results
Type
Article (51920)
Company Profile (653)
Press Release (625014)
Multimedia
Podcasts (119)
Webinars (21)
Section
Business (185205)
Career Advice (2540)
Deals (33505)
Drug Delivery (130)
Drug Development (79609)
Employer Resources (158)
FDA (17459)
Job Trends (14795)
News (326417)
Policy (35100)
Tag
Academia (2709)
Academic (1)
Accelerated approval (17)
Adcomms (33)
Allergies (121)
Alliances (48862)
ALS (137)
Alzheimer's disease (1575)
Antibody-drug conjugate (ADC) (242)
Approvals (17524)
Artificial intelligence (465)
Autoimmune disease (84)
Automation (28)
Bankruptcy (325)
Best Places to Work (11617)
BIOSECURE Act (23)
Biosimilars (166)
Biotechnology (408)
Bladder cancer (129)
Brain cancer (50)
Breast cancer (487)
Cancer (3860)
Cardiovascular disease (338)
Career advice (2145)
Career pathing (35)
CAR-T (229)
CDC (50)
Cell therapy (619)
Cervical cancer (32)
Clinical research (66855)
Collaboration (1359)
Compensation (696)
Complete response letters (59)
COVID-19 (2839)
CRISPR (78)
C-suite (561)
Cystic fibrosis (132)
Data (4629)
Decentralized trials (2)
Denatured (30)
Depression (107)
Diabetes (442)
Diagnostics (6517)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (41)
Drug discovery (214)
Drug pricing (190)
Drug shortages (35)
Duchenne muscular dystrophy (203)
Earnings (75510)
Editorial (54)
Employer branding (18)
Employer resources (143)
Events (97694)
Executive appointments (885)
FDA (20019)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (1213)
Gene editing (164)
Generative AI (44)
Gene therapy (516)
GLP-1 (964)
Government (4980)
Grass and pollen (6)
Guidances (369)
Healthcare (18148)
HIV (44)
Huntington's disease (38)
IgA nephropathy (62)
Immunology and inflammation (212)
Immuno-oncology (20)
Indications (57)
Infectious disease (3078)
Inflammatory bowel disease (175)
Inflation Reduction Act (14)
Influenza (96)
Intellectual property (194)
Interviews (461)
IPO (15538)
IRA (55)
Job creations (3618)
Job search strategy (1781)
Kidney cancer (13)
Labor market (70)
Layoffs (540)
Leadership (35)
Legal (8261)
Liver cancer (85)
Longevity (12)
Lung cancer (555)
Lymphoma (270)
Machine learning (31)
Management (56)
Manufacturing (638)
MASH (135)
Medical device (13489)
Medtech (13513)
Mergers & acquisitions (18849)
Metabolic disorders (1117)
Multiple sclerosis (138)
NASH (20)
Neurodegenerative disease (210)
Neuropsychiatric disorders (57)
Neuroscience (2566)
NextGen: Class of 2025 (6628)
Non-profit (4409)
Now hiring (45)
Obesity (539)
Opinion (297)
Ovarian cancer (133)
Pain (171)
Pancreatic cancer (159)
Parkinson's disease (224)
Partnered (29)
Patents (421)
Patient recruitment (326)
Peanut (56)
People (53251)
Pharmaceutical (129)
Pharmacy benefit managers (29)
Phase I (20606)
Phase II (28999)
Phase III (22393)
Pipeline (2759)
Policy (284)
Postmarket research (2711)
Preclinical (8562)
Press Release (70)
Prostate cancer (198)
Psychedelics (45)
Radiopharmaceuticals (260)
Rare diseases (656)
Real estate (5680)
Recruiting (65)
Regulatory (25481)
Reports (43)
Research institute (2469)
Resumes & cover letters (418)
Rett syndrome (15)
RNA editing (13)
RSV (74)
Schizophrenia (133)
Series A (203)
Series B (148)
Service/supplier (25)
Sickle cell disease (78)
Special edition (26)
Spinal muscular atrophy (158)
Sponsored (39)
Startups (3553)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (94)
The Weekly (87)
Vaccines (998)
Venture capital (60)
Weight loss (383)
Women's health (49)
Worklife (18)
Date
Today (257)
Last 7 days (768)
Last 30 days (2803)
Last 365 days (30430)
2025 (25466)
2024 (34715)
2023 (38973)
2022 (49871)
2021 (54060)
2020 (52991)
2019 (45844)
2018 (35238)
2017 (33005)
2016 (31928)
2015 (36552)
2014 (28899)
2013 (24286)
2012 (26034)
2011 (26522)
2010 (24099)
Location
Africa (916)
Alabama (66)
Alaska (7)
Arizona (208)
Arkansas (13)
Asia (42644)
Australia (7069)
California (8889)
Canada (2714)
China (887)
Colorado (376)
Connecticut (396)
Delaware (262)
Europe (94142)
Florida (1363)
Georgia (306)
Hawaii (3)
Idaho (53)
Illinois (714)
India (52)
Indiana (430)
Iowa (20)
Japan (332)
Kansas (113)
Kentucky (37)
Louisiana (21)
Maine (59)
Maryland (1221)
Massachusetts (6553)
Michigan (244)
Minnesota (511)
Mississippi (3)
Missouri (121)
Montana (27)
Nebraska (24)
Nevada (95)
New Hampshire (77)
New Jersey (2593)
New Mexico (29)
New York (2437)
North Carolina (1227)
North Dakota (9)
Northern California (4037)
Ohio (266)
Oklahoma (18)
Oregon (44)
Pennsylvania (1830)
Puerto Rico (20)
Rhode Island (41)
South America (1227)
South Carolina (48)
South Dakota (1)
Southern California (3447)
Tennessee (138)
Texas (1367)
United States (32557)
Utah (263)
Virginia (241)
Washington D.C. (78)
Washington State (748)
West Virginia (3)
Wisconsin (94)
Wyoming (2)
677,602 Results for "astellas pharma us".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
GSK Points to ‘Macro Factors’ To Explain US Shingrix Demand Crash
Shingrix sales in the U.S. took a 15% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales, after
Sanofi reported
a similar decline last week.
October 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Uniphar announces U.S. expansion, integrating leading companies and appointing new senior leadership
- New integration aligns U.S. operations, unifying RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions and BESTMSLs under the Uniphar brand. - Mike Ebhardt is appointed President of Uniphar Pharma Services U.S., alongside Cindy Thompson as Vice President of Operations and Transformation.
November 3, 2025
·
1 min read
Earnings
Merck Vaccine Sales Drop as US Declines Strike Another Pharma
While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.
October 30, 2025
·
1 min read
·
Dan Samorodnitsky
Job Trends
Almost 1/3 Eyeing Job Options Outside US,
BioSpace
Finds
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to a
BioSpace
LinkedIn poll. Career coaches discuss why people are considering relocating and what they should do before heading for the exit.
October 30, 2025
·
4 min read
·
Angela Gabriel
Press Releases
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program
October 28, 2025
·
2 min read
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
Listen now for a high-level discussion on overcoming pharmaceutical supply chain challenges through end-to-end integration.
September 17, 2025
·
1 min read
·
BioSpace Insights
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
LEO Pharma Unveils Data on the U.S. Prevalence of Chronic Hand Eczema at Fall Clinical Dermatology Conference
October 27, 2025
·
7 min read
Press Releases
Aptar Pharma’s Unidose System Delivers Enbumyst™, First U.S. FDA-Approved Intranasal Diuretic
September 18, 2025
·
2 min read
1 of 67,761
Next
